603998.SS
Hunan Fangsheng Pharmaceutical Co., Ltd. [603998.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603998.SS Stock Summary
In the News
603998.SS Financial details
Company Rating
-
Market Cap
4.57B
Income
177.64M
Revenue
1.65B
Book val./share
-
Cash/share
-
Dividend
0.35
Dividend %
3.21%
Employees
1.6K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2023
P/E
26.88
Forward P/E
-
PEG
1.68
P/S
3
P/B
3.36
P/C
-
P/FCF
-37.93
Quick Ratio
0.67
Current Ratio
1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.42
EPS next Y
-
EPS next Q
-
EPS this Y
318.75%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
31.56%
Revenue last 5Y
11.26%
Revenue Q/Q
-14.04%
EPS Q/Q
-17.2%
-
-
-
-
SMA20
-
SMA50
-
SMA100
9.09%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
13%
ROC
0.11%
Gross Margin
69%
Oper. Margin
13%
Profit Margin
11%
Payout
99%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.12-14.73
52W High
-15.79%
52W Low
+68.43%
RSI
47
Rel Volume
1.08
Avg Volume
5.85M
Volume
6.33M
Perf Week
-6.28%
Perf Month
4.52%
Perf Quarter
22.18%
Perf Half Y
20.18%
-
-
-
-
Beta
0.34
-
-
Volatility
0.29%, 0.42%
Prev Close
0.17%
Price
11.79
Change
0.77%
603998.SS Financial Performance
603998.SS Frequently Asked Questions
What is Hunan Fangsheng Pharmaceutical Co., Ltd. stock symbol ?
Hunan Fangsheng Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 603998.SS
What is Hunan Fangsheng Pharmaceutical Co., Ltd. stock quote today ?
Hunan Fangsheng Pharmaceutical Co., Ltd. stock price is $11.79 today.
Is Hunan Fangsheng Pharmaceutical Co., Ltd. stock public?
Yes, Hunan Fangsheng Pharmaceutical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 5.85M
- Market Capitalization 4.57B
- Employee 1.6K
- CEO Ms. Xiaoli Zhou
- Headquarters Changsha,CN
- IPO Date 2014-12-05
-
Website
https://www.fangsheng.com.cn 
Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in Changsha, China.
